Replies to post #319898 on Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

My position has been ipix is going along for the ride. Leo did not pursue covid but rather other institutions came to ipix looking into brilacidin. I think leo was a reluctant passenger until May when he forked over the 35k. Now he is taking it more serious with input from the rbl who submitted their grant in June. Leo also said he expects to hear back on grant in September based upon 2-3 month review time

[olden_grumpini]

I agree that it’s ridiculous to ask for $35k if the drug you’re researching is the world-changing COVID therapeutic.

My assumption is that the RBL is doing benchmark testing on hundreds of drugs, including B. These hundreds of drugs are considered the longest of long-shots. They don’t merit grants, they cannot attract private financing, and the companies/institutions that control them cannot afford to do the benchmark testing on their own. The government is doing this testing so that every possibility is explored.

When the results are released, I expect B to be a line item on a table. Hopefully, it will appear among chemicals that merit further investigation. And I'm hopeful that inclusion on that list will spark some interest.